Evidence map›Paper›PMID 31534156›Full record

ArticleScientific reports2019

Multi-view based integrative analysis of gene expression data for identifying biomarkers.

Zi-Yi Yang, Xiao-Ying Liu, Jun Shu, Hui Zhang, Yan-Qiong Ren, Zong-Ben Xu, Yong Liang

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zi-Yi YangFaculty of Information Technology & State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, 999078, Macau, China.
Xiao-Ying LiuComputer Engineering Technical College, Guangdong Polytechnic of Science and Technology, Zhuhai, 519090, China.
Jun ShuSchool of Mathematics and Statistics & Ministry of Education Key Lab of Intelligent Networks and Network Security, Xi'an Jiaotong University, Xi'an, 710049, China.
Hui ZhangFaculty of Information Technology & State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, 999078, Macau, China.
Yan-Qiong RenFaculty of Information Technology & State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, 999078, Macau, China.ORCID http://orcid.org/0000-0002-7619-1400
Zong-Ben XuSchool of Mathematics and Statistics & Ministry of Education Key Lab of Intelligent Networks and Network Security, Xi'an Jiaotong University, Xi'an, 710049, China.
Yong LiangFaculty of Information Technology & State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, 999078, Macau, China. yliang@must.edu.mo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread applications in microarray technology have produced the vast quantity of publicly available gene expression datasets. However, analysis of gene expression data using biostatistics and machine learning approaches is a challenging task due to (1) high noise; (2) small sample size with high dimensionality; (3) batch effects and (4) low reproducibility of significant biomarkers. These issues reveal the complexity of gene expression data, thus significantly obstructing microarray technology in clinical applications. The integrative analysis offers an opportunity to address these issues and provides a more comprehensive understanding of the biological systems, but current methods have several limitations. This work leverages state of the art machine learning development for multiple gene expression datasets integration, classification and identification of significant biomarkers. We design a novel integrative framework, MVIAm - Multi-View based Integrative Analysis of microarray data for identifying biomarkers. It applies multiple cross-platform normalization methods to aggregate multiple datasets into a multi-view dataset and utilizes a robust learning mechanism Multi-View Self-Paced Learning (MVSPL) for gene selection in cancer classification problems. We demonstrate the capabilities of MVIAm using simulated data and studies of breast cancer and lung cancer, it can be applied flexibly and is an effective tool for facing the four challenges of gene expression data analysis. Our proposed model makes microarray integrative analysis more systematic and expands its range of applications.

Indexed as

AlgorithmsBiomarkers, TumorGene ExpressionGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMachine LearningOligonucleotide Array Sequence AnalysisReproducibility of ResultsSequence Analysis, DNATranscriptomeBiomarkers, Tumor

Identifiers

PMID31534156
PMCPMC6751173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.